Speaker Profile

M.D., Ph.D., Professor & Chief, Genomic Medicine, UC Davis

Biography
Dr. Suma Shankar is a Professor in the Departments of Pediatrics and Ophthalmology and is Chief of Genomic Medicine at UC Davis. She is the Director of Precision Genomic Program and holds the Albert Rowe Endowed Chair of Genetics II. She graduated from Bangalore Medical College, India and has a PhD from UIowa. She is board certified in Medical Genetics from the American College of Medical Genetics & Genomics. She initiated the UC Davis Precision Genomics program to provide personalized health care to all in an equitable manner using state-of-the-art whole genome sequencing to determine the underlying genetic etiology in individuals with nonverbal autism/ neurodevelopmental disorders and in those going through “Diagnostic Odysseys.” Additionally, in collaboration with the Mouse Biology Program at UC Davis, she has initiated several small animal models resulting in new gene discovery, proving pathogenicity of several “variants of uncertain significance” and provided models for functional studies and translational research.


Talk


Clinical & Research Tools Showcase:
UC Davis

Nationally renowned UC Davis Medical Center is a leading referral center for the most seriously injured or ill patients and the most medically complex cases. It is nationally ranked in nine adult and five pediatric specialty areas.

Advancing translational genomics in the clinic (ATGC)
Genome sequencing and translational research can end diagnostic odysseys resulting in precision care and management.

 Session Abstract – PMWC 2023 Silicon Valley

Showcase Track S2 - January 25 2.45 P.M.-4.00 P.M.,Showcase Track S2 - January 26 1.30 P.M.-4.00 P.M.,Showcase Track S2 - January 27 1.15 P.M.-1.30 P.M.


The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.